Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion. Precision BioSciences (DTIL) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Precision BioSciences, Inc. (fasadlepnina.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Precision BioSciences. Based on 2 Wall Street analysts offering 12 month price targets for Precision BioSciences in the last 3 months. The average price target is $ with a high. DURHAM, N.C. --(BUSINESS WIRE)--Jul. 29, Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary.
Precision BioSciences is selling for as of the 14th of July This is a percent increase since the beginning of the trading day. The stock's. Stock Information · Analyst Coverage · SEC Filings · Corporate Governance · Sustainability · Investor FAQs · Partnering. Pipeline. In Vivo Gene Editing Pipeline. DTIL | Complete Precision Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Precision BioSciences Shares Outstanding | DTIL ; Bio-Techne Corp (TECH), United States, $B ; Exact Sciences (EXAS), United States, $B. DTIL - Precision BioSciences, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Precision BioSciences Announces Closing of Underwritten Offering of Common Stock · $ per share, for total gross proceeds of approximately · $50 million. Precision BioSciences Inc DTIL:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/29/24 · 52 Week Low. Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using. Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. The Company's common stock is expected to commence trading on a split-adjusted basis when the markets open on February 14, under the existing trading. Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies.
Research Precision BioSciences' (Nasdaq:DTIL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Wall Street Analysts Believe Precision BioSciences (DTIL) Could Rally %: Here's is How to Trade. The consensus price target hints at a % upside. Precision BioSciences, Inc NASDAQ: DTIL is a clinical stage gene editing company developing ex vivo allogeneic CAR T immunotherapies and in vivo therapies for. Precision BioSciences, Inc. (Nasdaq: DTIL), is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS®. Track Precision Biosciences Inc (DTIL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Discover real-time Precision BioSciences, Inc. Common Stock (DTIL) stock prices, quotes, historical data, news, and Insights for informed trading and. Company has been rated SELL since 06/20/ The Company Scores Poorly in MarketGrader's Growth at a Reasonable Price Analysis. Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics.
Stay up-to-date on Precision BioSciences, Inc. Common Stock (DTIL) news with the latest updates, breaking headlines, news articles, and more from around the. At Precision BioSciences we are using our novel ARCUS genome editing technology to develop a new class of medicines designed to overcome and potentially cure. Precision BioSciences Reports Third Quarter Financial Results and Provides Business Update · $21 million. · $8 million near-term milestone payment, up to. Interactive chart of historical stock value for Precision BioSciences over the last 10 years. The value of a company is typically represented by its market. Precision BioSciences's posts ; Sep 3 · ; Aug 13 · ; Aug 1 · ; Jul 31 · ; Jul 29 ·
Precision BioSciences Reports Third Quarter Financial Results and Provides Business Update · $21 million. · $8 million near-term milestone payment, up to. (DTIL) is According to Precision BioSciences, Inc.'s latest financial reports and current stock price. The company's current Current Ratio is This. News for Precision Biosciences Stock (DTIL) · Precision BioSciences' (DTIL) Stock Up This Week: Here's Why · Looking For the Best Penny Stocks to Buy? · Precision.